Keysight Technologies Inc vs 22nd Century Group Inc — how do they compare? Keysight Technologies Inc trades at $344 (market cap $58.74B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Keysight Technologies Inc is far larger — about 38644.7× 22nd Century Group Inc's market cap, and Keysight Technologies Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| KEYS | XXII | |
|---|---|---|
Market Cap | $58.74B | $1.52M |
Sector | Technology | Technology |
52-Week High | $373.34 | $801.00 |
52-Week Low | $158.51 | $3.72 |
Enterprise Value | $59.08B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
Keysight Technologies (KEYS) trades at $354.38, up 5.66% with strong bullish momentum. The stock shows robust fundamentals with revenue of $5.38B and net income of $850M in 2025, supported by consistent earnings beats. Technical indicators signal bullish trends with moving averages supporting upward momentum, while RSI suggests mild overbought conditions. Recent news highlights institutional buying and product innovations in 5G and photonics.
Outlook remains positive with analyst consensus at Buy (81%) and $396.56 price target, offering ~12% upside. Risks include elevated valuation multiples (P/E 55.35) and competitive pressures in tech instruments. Earnings growth and strategic acquisitions position KEYS for continued strength, though investors should monitor execution on $6.1B revenue guidance for 2026.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →